{"schema_version":"1.0","canonical_url":"https://patentable.app/patents/US-11485786","patent":{"patent_number":"US-11485786","title":"Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders","assignee":null,"inventors":[],"filing_date":"2019-08-15T00:00:00.000Z","publication_date":"2022-11-01T00:00:00.000Z","cpc_codes":["C12Q","C12Q","G01N"],"num_claims":15,"abstract":"The invention relates to the prophylaxis and/or treatment of fibrosis and/or fibrotic diseases by means of antibodies. Above all, the invention relates to the administration of an anti-alpha-v integrin (receptor) antibody to patients suffering from fibrosis and/or fibrotic diseases, including but not limited to systemic sclerosis (SSc). More specifically, the instant invention relates to the treatment of fibrotic diseases of the skin, lung, heart, liver and/or kidney by means of said antibody. Even more specifically, the instant invention relates to the administration of a recombinant, de-immunized monoclonal antibody targeting αv-integrins patients suffering from systemic sclerosis, including, but not limited to systemic sclerosis of the skin, lung, heart and/or kidney by means of the anti-alpha-v integrin antibody DI17E6 and structural mutants or modifications thereof."},"analysis":{"summary":null,"layman_explanation":null,"technical_analysis":null,"business_analysis":null,"faqs":null,"topics":[],"tech_cluster":null},"seo":{"title":"Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders","description":"The invention relates to the prophylaxis and/or treatment of fibrosis and/or fibrotic diseases by means of antibodies. Above all, the invention relates to the administration of an anti-alpha-v integri","keywords":[]},"attribution":{"source":"Patentable","source_url":"https://patentable.app","canonical_url":"https://patentable.app/patents/US-11485786","license":"CC-BY-4.0-like","license_terms":"AI-generated analysis on this page (summary, layman_explanation, technical_analysis, business_analysis, faqs) may be reused with attribution and a visible link back to the canonical URL above. Patent abstracts, claims, and bibliographic data are USPTO public domain.","required_link":"https://patentable.app/patents/US-11485786","citation_suggestion":"Patentable. \"Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders\" (US-11485786). https://patentable.app/patents/US-11485786","copyright_holder":"Nomic Interactive Technology LLC"},"links":{"html":"https://patentable.app/patents/US-11485786","json":"https://patentable.app/api/llm-context/US-11485786","site":"https://patentable.app","llms_txt":"https://patentable.app/llms.txt"},"generated_at":"2026-05-31T05:56:35.940Z"}